Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Monaker Group, Inc. (MKGI) Carves Niche in Explosive Sector

Technology-driven Monaker Group (OTCQB: MKGI) is rapidly building a presence in the travel and alternative lodging marketplace with NextTrip.com. Travel and tourism are among the world’s largest industries, and alternative lodging is the fastest growing sector in this $1.25 trillion market. NextTrip.com is the first comprehensive booking solution to include conventional lodging, alternative lodging, and […]

Halitron, Inc. (HAON) Leveraging Proven Roll-Up M&A Strategy

Roll-ups are back now that Bernard Findley, chief executive officer of Halitron, Inc. (OTC: HAON), is in the driver’s seat. Making its first appearance back in the glorious nineties, the rollup, as a strategy, has had many successes. One such success is reported in the Wharton School Entrepreneurship Blog in an article titled ‘Why I […]

Oakridge Global Energy Solutions (OGES): Lithium-ion is the Future of Battery Technology

Lithium-ion batteries are common in home electronics. They are one of the most popular types of rechargeable batteries for portable electronics, with a high energy density, tiny memory effect and low self-discharge. Beyond consumer electronics, lithium-ion batteries are also growing in popularity for military, electric vehicle and aerospace applications. For example, lithium-ion batteries are becoming […]

 

From Our Blog

Soligenix Inc. (NASDAQ: SNGX) Builds Momentum in Fight Against Rare, Chronic Cancer

February 2, 2026

Cutaneous T-cell lymphoma (“CTCL”) remains a cancer with limited treatment options, persistent symptoms and long-term quality-of-life challenges for patients, even decades after its classification as a distinct disease. Despite medical advances in oncology, many people living with CTCL continue to cycle through therapies that offer only partial relief or introduce new burdens. Soligenix (NASDAQ: SNGX) […]

Rotate your device 90° to view site.